Proactive headlines: FastForward Innovations, Love Hemp, Shield Therapeutics…
A look at today s main headlines from the Proactive newswire
FastForward Innovations Ltd (LON:FFWD) said its investee Little Green Pharma Ltd (LGP) has announced an additional A$2.5mln (£1.3mln) purchase order for its high THC cannabis flower medicine from an existing client.
Shield Therapeutics PLC (LON:STX) has appointed a new chief executive with “deep knowledge and previous experience in the US iron deficiency marketplace”.
Quantum Blockchain Technologies PLC (LON:QBT) has updated investors on the current status of Clear Leisure 2017’s (CL17’s) legal action against Sipiem SpA’s previous board and internal audit committee.
SOC Telemed to Participate in Upcoming Investor Conference
News provided by
Share this article
Share this article
RESTON, Va., May 28, 2021 /PRNewswire/ SOC Telemed, Inc. ( SOC ), the largest national provider of acute care telemedicine, today announced that they will participate in the following upcoming investor conferences:
The 41st Annual William Blair Growth Stock Conference, including one-on-one meetings and a presentation by John Kalix, Chief Executive Officer, and Chris Knibb, Chief Financial Officer, on Wednesday, June 2, 2021 at 1:00 p.m. E.T.
The Jefferies Virtual Healthcare Conference, including a one-on-one meetings and a fireside chat with Hai Tran, President and Chief Operating Officer, and Ron Egan, Chief Customer Officer, on Wednesday, June 2, 2021 at 3:00 p.m. E.T.
Calliditas Therapeutics to Present at Jefferies Virtual Healthcare Conference
STOCKHOLM, May 28, 2021 /PRNewswire/
Calliditas Therapeutics AB (publ) ( Calliditas ) today announced that management will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 2:30 pm CET/8:30 am ET. Calliditas will also host 1x1 meetings during the conference. Details for the presentation are as follows:
Jefferies Virtual Healthcare Conference
Time: 2:30 pm CET / 8:30 am ET
Registration Link: https://wsw.com/webcast/jeff174/register.aspx?conf=jeff174&page=calt&mmid=3325730&refer=meetmax&firstname=&lastname=
The webcast will be archived for a period of 30 days following the conclusion of the event.
For further information, please contact:
Wave Life Sciences to Present at Jefferies Virtual Healthcare Conference
CAMBRIDGE, Mass., May 28, 2021 (GLOBE NEWSWIRE) Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to give a presentation at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 11:30 a.m. ET. Dr. Bolno will provide a corporate update and discuss Wave’s pipeline programs, including the first
in vivo data from the company’s ADAR editing discovery program for alpha-1 antitrypsin deficiency (AATD).
A live webcast of the presentation will be available on the investor relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for 90 days following the event.